Tricyclic cytoprotective compounds

Details for Australian Patent Application No. 2006210727 (hide)

Owner Hunter-Fleming Limited

Inventors Khalaf, Abedawn Ibrahim; Wulfert, Ernst; Mackay, Simon Paul; Johnston, Blair Fraser

Agent Shelston IP

Pub. Number AU-B-2006210727

PCT Pub. Number WO2006/082409

Priority 0502267.8 03.02.05 GB

Filing date 2 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 13 October 2011

International Classifications

C07D 209/88 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/404 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 209/94 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/082409 Priority application(s): WO2006/082409

13 October 2011 Application Accepted

  Published as AU-B-2006210727

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210730-Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors

2006210724-Human antibodies and proteins